Source link : https://www.newshealth.biz/health-news/oral-semaglutide-may-boost-liver-health-in-type-2-diabetes/
TOPLINE: A 48-week oral semaglutide treatment regimen for type 2 diabetes (T2D) reduces weight and improves liver steatosis, liver stiffness, and liver enzyme levels in patients with metabolic dysfunction–associated steatotic liver disease (MASLD), with a similar safety profile to that of subcutaneous semaglutide. METHODOLOGY: Obesity and T2D increase the likelihood of MASLD, which can cause […]
Author : News Health
Publish date : 2024-10-24 13:05:05
Copyright for syndicated content belongs to the linked Source.